Literature DB >> 6276712

Phenoxybenzamine and dibenamine interactions with calcium channel effectors of the muscarinic receptor.

E El-Fakahany, E Richelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6276712

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  6 in total

1.  Affinity and efficacy correlate with chemical structure more than potency does in a series of pentatomic cyclic muscarinic agonists.

Authors:  P Angeli; L Brasili; M Giannella; F Gualtieri; M Pigini
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

2.  The determination of presynaptic KA values of methacholine and pilocarpine and of a presynaptic receptor reserve in the rat perfused heart.

Authors:  P Fuchs; H Fuder
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

3.  1,4-Dithiothreitol-induced changes in histamine H1-agonist efficacy and affinity in the longitudinal smooth muscle of guinea-pig ileum.

Authors:  J Donaldson; S J Hill
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

4.  Effects of the irreversible alpha-adrenoceptor antagonists phenoxybenzamine and benextramine on the effectiveness of nifedipine in inhibiting alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in pithed rats.

Authors:  P B Timmermans; M J Thoolen; M J Mathy; B Wilffert; A de Jonge; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

5.  Affinity and efficacy of racemic, (+)-, and (-)-methacholine in muscarinic inhibition of [3H]-noradrenaline release.

Authors:  H Fuder; B Jung
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

6.  Characterization of the muscarinic receptor in human tracheal smooth muscle.

Authors:  C J van Koppen; J F Rodrigues de Miranda; A J Beld; M W Hermanussen; J W Lammers; C A van Ginneken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.